Pyrimidine derivatives as GPCR modttlators for use in the treatment of obesity and diabetes

Details for Australian Patent Application No. 2009330206 (hide)

Owner Schering Corporation

Inventors Neustadt, Bernard R.; Stamford, Andrew; Hao, Jinsong; Jayne, Charles Lee; Xia, Yan

Agent Spruson & Ferguson

Pub. Number AU-A-2009330206

PCT Pub. Number WO2010/075269

Priority 61/140,149 23.12.08 US

Filing date 21 December 2009

Wipo publication date 1 July 2010

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 471/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

7 July 2011 PCT application entered the National Phase

  PCT publication WO2010/075269 Priority application(s): WO2010/075269

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009330208-Bicyclic heterocycle derivatives and methods of use thereof

2009330204-Method of manufacturing high strength glass fibers in a direct melt operation and products formed there from